TRAF3IP2 Antikörper (N-Term)
Kurzübersicht für TRAF3IP2 Antikörper (N-Term) (ABIN928664)
Target
Alle TRAF3IP2 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- N-Term
-
Aufreinigung
- Purified
-
Immunogen
- TRAF3 IP2 antibody was raised in rabbit using the N terminal of TRAF3 P2 as the immunogen
-
-
-
-
Applikationshinweise
-
WB: 0.2-1 µg/mL
Optimal conditions should be determined by the investigator. -
Kommentare
-
TRAF3IP2 Blocking Peptide, catalog no. 33R-4101, is also available for use as a blocking control in assays to test for specificity of this TRAF3IP2 antibody
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Lyophilized
-
Konzentration
- Lot specific
-
Buffer
- Lyophilized powder. Add 50 µL of distilled water. Final antibody concentration is 1 mg/mL in PBS buffer.
-
Handhabung
- Avoid repeated freeze/thaw cycles.
-
Lagerung
- 4 °C/-20 °C
-
Informationen zur Lagerung
- Store at 4 °C, following reconstitution, aliquot and store at -20 °C.
-
-
- TRAF3IP2 (TRAF3 Interacting Protein 2 (TRAF3IP2))
-
Andere Bezeichnung
- TRAF3IP2
-
Hintergrund
- TRAF3IP2 encodes a protein involved in regulating responses to cytokines by members of the Rel/NF-kappaB transcription factor family. These factors play a central role in innate immunity in response to pathogens, inflammatory signals and stress. This gene product interacts with TRAF proteins (tumor necrosis factor receptor-associated factors) and either I-kappaB kinase or MAP kinase to activate either NF-kappaB or Jun kinase. Synonyms: Polyclonal TRAF3IP2 antibody, Anti-TRAF3IP2 antibody, TRAF3 interacting protein 2 antibody, ACT1 antibody, C6orf2 antibody, C6orf4 antibody, C6orf5 antibody, C6orf6 antibody, CIKS antibody, DKFZp586G0522 antibody, MGC3581 antibody.
-
Pathways
- Production of Molecular Mediator of Immune Response
Target
-